1160247-07-3

Basic information

• Product Name: tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate
• Synonyms: tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate;3-Oxo-1-oxa-4,9-diaza-spiro[5.5]undecane-9-carboxylic acid tert-butyl ester;ert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate;3-oxo-1-Oxa-4,9-diazaspiro[5.5]undecane-9-carboxylic acid 1,1-dimethylethyl ester;1-Oxa-4,9-diazaspiro[5.5]undecane-9-carboxylic acid, 3-oxo-, 1,1-dimethylethyl ester
• CAS NO: 1160247-07-3
• Molecular Formula: C₁₃H₂₂N₂O₄
• Molecular Weight: 270.32478
• Mol File: 1160247-07-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 454.6±45.0 °C(Predicted)
• Appearance: /
• Density: 1.18±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.87±0.20(Predicted)
• CAS DataBase Reference: tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate(1160247-07-3)
• EPA Substance Registry System: tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate(1160247-07-3)

Safety Data

• Hazardous Substances Data: 1160247-07-3(Hazardous Substances Data)

Usage

General Description

Tert-Butyl 3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate is a complex organic compound with a spirocyclic structure. It consists of a tert-butyl group, a ketone group, an ester group, and a diazaspiro ring. The compound is primarily used in organic synthesis and medicinal chemistry, where it can be employed as a building block for the construction of more complex molecules, and as a potential drug candidate due to its unique structure and potential pharmacological properties. Its spirocyclic structure also makes it a valuable tool for the study of spirocyclic compounds and their properties.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 41661-47-6 piperidin-4-one 
• 819800-93-6 tert-butyl 4-hydroxy-4-(nitromethyl)-piperidine-1-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 147804-30-6 1-oxa-6-aza-spiro-[2.5]octane-6-caboxylic acid tert-butyl ester 
• 392331-66-7 4-aminomethyl-4-hydroxypiperidine-1-carboxylic acid tert-butyl ester 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 930785-40-3 1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylic acid tert-butyl ester 
• 1352926-03-4 tert-butyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate 

Relevant articles and documents

HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS

The present invention provides, in part, heterocyclic spiro compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or sa

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

ALKYL AND ARYL DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN

The present invention relates to compounds of general formula (I) having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.